Clinical Trial Update: Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the diagnostic performance of 18F-fluciclovine PET for detecting recurrent brain metastases has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Axumin (fluciclovine F-18) (fluciclovine F-18)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Brain Metastases | Phase 3 | Status: COMPLETED | Results posted: 2025-08-28